Efficacy of Deucravacitinib over Time in Psoriasis by Baseline Total Body Surface Area: Post Hoc Analysis of the Randomized, Double-Blind, Placebo-Controlled Phase 3b 4 PSORIATYK SCALP Trial. J of Skin 2025, 9 (2), s537. https://doi.org/10.25251/skin.10.supp.537.